{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:37:57Z","timestamp":1765039077083},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T00:00:00Z","timestamp":1227744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s00403-008-0919-1","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T12:43:41Z","timestamp":1227703421000},"page":"719-723","source":"Crossref","is-referenced-by-count":11,"title":["Pretibial myxedema is associated with polymorphism in exon 1 of CTLA-4 gene in patients with Graves\u2019 ophthalmopathy"],"prefix":"10.1007","volume":"301","author":[{"given":"Omid","family":"Khalilzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoda","family":"Mojazi Amiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Tahvildari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Esteghamati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra","family":"Mobarra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Tehranchinia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Rashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliakbar","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,27]]},"reference":[{"key":"919_CR1","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1399-0039.2004.00312.x","volume":"64","author":"SS Amundsen","year":"2004","unstructured":"Amundsen SS, Naluai AT, Ascher H et al (2004) Genetic analysis of the CD28\/CTLA4\/ICOS (CELIAC3) region in coeliac disease. Tissue Antigens 64:593\u2013599. doi: 10.1111\/j.1399-0039.2004.00312.x","journal-title":"Tissue Antigens"},{"key":"919_CR2","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1210\/jc.2002-030010","volume":"88","author":"RS Bahn","year":"2003","unstructured":"Bahn RS (2003) Clinical review 157: pathophysiology of Graves\u2019 ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88:1939\u20131946. doi: 10.1210\/jc.2002-030010","journal-title":"J Clin Endocrinol Metab"},{"key":"919_CR3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/08916930500050319","volume":"38","author":"Y Ban","year":"2005","unstructured":"Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y (2005) Association of a CTLA-4 3\u2019 untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity 38:151\u2013153. doi: 10.1080\/08916930500050319","journal-title":"Autoimmunity"},{"key":"919_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","volume":"67","author":"T Bednarczuk","year":"2007","unstructured":"Bednarczuk T, Gopinath B, Ploski R, Wall JR (2007) Susceptibility genes in Graves\u2019 ophthalmopathy: searching for a needle in a haystack? Clin Endocrinol (Oxf) 67:3\u201319. doi: 10.1111\/j.1365-2265.2007.02854.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"919_CR5","doi-asserted-by":"crossref","DOI":"10.1002\/9780470750520","volume-title":"Rook\u2019s textbook of dermatology","author":"DA Burns","year":"2004","unstructured":"Burns DA, Breathnach SM, Cox N, Griffiths CE (2004) Rook\u2019s textbook of dermatology. Blackwell Science, Oxford"},{"key":"919_CR6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1523-1747.ep12543646","volume":"71","author":"HS Cheung","year":"1978","unstructured":"Cheung HS, Nicoloff JT, Kamiel MB, Spolter L, Nimni ME (1978) Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema. J Invest Dermatol 71:12\u201317. doi: 10.1111\/1523-1747.ep12543646","journal-title":"J Invest Dermatol"},{"key":"919_CR7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.clim.2005.09.017","volume":"118","author":"DA Chistiakov","year":"2006","unstructured":"Chistiakov DA, Savost\u2019anov KV, Turakulov RI, Efremov IA, Demurov LM (2006) Genetic analysis and functional evaluation of the C\/T(\u2212318) and A\/G(\u22121661) polymorphisms of the CTLA-4 gene in patients affected with Graves\u2019 disease. Clin Immunol 118:233\u2013242. doi: 10.1016\/j.clim.2005.09.017","journal-title":"Clin Immunol"},{"key":"919_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-199401000-00001","volume":"73","author":"V Fatourechi","year":"1994","unstructured":"Fatourechi V, Pajouhi M, Fransway AF (1994) Dermopathy of Graves disease (pretibial myxedema). Review of 150 cases. Medicine (Baltimore) 73:1\u20137. doi: 10.1097\/00005792-199401000-00001","journal-title":"Medicine (Baltimore)"},{"key":"919_CR9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/10507250360731541","volume":"13","author":"V Fatourechi","year":"2003","unstructured":"Fatourechi V, Bartley GB, Eghbali-Fatourechi GZ, Powell CC, Ahmed DD, Garrity JA (2003) Graves\u2019 dermopathy and acropachy are markers of severe Graves\u2019 ophthalmopathy. Thyroid 13:1141\u20131144. doi: 10.1089\/10507250360731541","journal-title":"Thyroid"},{"key":"919_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2165\/00128071-200506050-00003","volume":"6","author":"V Fatourechi","year":"2005","unstructured":"Fatourechi V (2005) Pretibial myxedema: pathophysiology and treatment options. Am J Clin Dermatol 6:295\u2013309. doi: 10.2165\/00128071-200506050-00003","journal-title":"Am J Clin Dermatol"},{"key":"919_CR11","first-page":"636","volume":"45","author":"J Furszyfer","year":"1970","unstructured":"Furszyfer J, Kurland LT, McConahey WM, Elveback LR (1970) Graves\u2019 disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin Proc 45:636\u2013644","journal-title":"Mayo Clin Proc"},{"key":"919_CR12","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.0105-2896.2005.00249.x","volume":"204","author":"SC Gough","year":"2005","unstructured":"Gough SC, Walker LS, Sansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102\u2013115. doi: 10.1111\/j.0105-2896.2005.00249.x","journal-title":"Immunol Rev"},{"key":"919_CR13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/clim.2001.5121","volume":"101","author":"H Hadj Kacem","year":"2001","unstructured":"Hadj Kacem H, Bellassoued M, Bougacha-Elleuch N, Abid M, Ayadi H (2001) CTLA-4 gene polymorphisms in Tunisian patients with Graves\u2019 disease. Clin Immunol 101:361\u2013365. doi: 10.1006\/clim.2001.5121","journal-title":"Clin Immunol"},{"key":"919_CR14","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1034\/j.1399-0039.1999.530112.x","volume":"53","author":"HF Harbo","year":"1999","unstructured":"Harbo HF, Celius EG, Vartdal F, Spurkland A (1999) CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53:106\u2013110. doi: 10.1034\/j.1399-0039.1999.530112.x","journal-title":"Tissue Antigens"},{"key":"919_CR15","first-page":"3733","volume":"81","author":"AE Heufelder","year":"1996","unstructured":"Heufelder AE, Wenzel BE, Scriba PC (1996) Antigen receptor variable region repertoires expressed by T cells infiltrating thyroid, retroorbital, and pretibial tissue in Graves\u2019 disease. J Clin Endocrinol Metab 81:3733\u20133739. doi: 10.1210\/jc.81.10.3733","journal-title":"J Clin Endocrinol Metab"},{"key":"919_CR16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ard.58.3.193","volume":"58","author":"J Heward","year":"1999","unstructured":"Heward J, Gordon C, Allahabadia A, Barnett AH, Franklyn JA, Gough SC (1999) The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis 58:193\u2013195","journal-title":"Ann Rheum Dis"},{"key":"919_CR17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/0891693032000114544","volume":"36","author":"T Kalantari","year":"2003","unstructured":"Kalantari T, Mostafavi H, Pezeshki AM et al (2003) Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves\u2019 disease. Autoimmunity 36:313\u2013316. doi: 10.1080\/0891693032000114544","journal-title":"Autoimmunity"},{"key":"919_CR18","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"2000","unstructured":"Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2019 disease. J Immunol 165:6606\u20136611","journal-title":"J Immunol"},{"key":"919_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0889-8529(18)30486-9","volume":"16","author":"JP Kriss","year":"1987","unstructured":"Kriss JP (1987) Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 16:409\u2013415","journal-title":"Endocrinol Metab Clin North Am"},{"key":"919_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.gene.6363752","volume":"2","author":"A Ligers","year":"2001","unstructured":"Ligers A, Teleshova N, Masterman T, Huang WX, Hillert J (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145\u2013152. doi: 10.1038\/sj.gene.6363752","journal-title":"Genes Immun"},{"key":"919_CR21","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2370.2004.00455.x","volume":"31","author":"H Nakkash-Chmaisse","year":"2004","unstructured":"Nakkash-Chmaisse H, Makki RF, Abdelhamid E, Fakhoury H, Salti NN, Salti I (2004) CTLA-4 gene polymorphism and its association with Graves\u2019 disease in the Lebanese population. Eur J Immunogenet 31:141\u2013143. doi: 10.1111\/j.1365-2370.2004.00455.x","journal-title":"Eur J Immunogenet"},{"key":"919_CR22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1089\/thy.2000.10.453","volume":"10","author":"YJ Park","year":"2000","unstructured":"Park YJ, Chung HK, Park DJ et al (2000) Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10:453\u2013459","journal-title":"Thyroid"},{"key":"919_CR23","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1089\/thy.2005.15.232","volume":"15","author":"A Petrone","year":"2005","unstructured":"Petrone A, Giorgi G, Galgani A et al (2005) CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves\u2019 disease in an Italian population. Thyroid 15:232\u2013238. doi: 10.1089\/thy.2005.15.232","journal-title":"Thyroid"},{"key":"919_CR24","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1210\/er.2002-0020","volume":"24","author":"BS Prabhakar","year":"2003","unstructured":"Prabhakar BS, Bahn RS, Smith TJ (2003) Current perspective on the pathogenesis of Graves\u2019 disease and ophthalmopathy. Endocr Rev 24:802\u2013835. doi: 10.1210\/er.2002-0020","journal-title":"Endocr Rev"},{"key":"919_CR25","first-page":"438","volume":"87","author":"KM Schwartz","year":"2002","unstructured":"Schwartz KM, Fatourechi V, Ahmed DD, Pond GR (2002) Dermopathy of Graves\u2019 disease (pretibial myxedema): long-term outcome. J Clin Endocrinol Metab 87:438\u2013446. doi: 10.1210\/jc.87.2.438","journal-title":"J Clin Endocrinol Metab"},{"key":"919_CR26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(99)01465-8","volume":"354","author":"B Vaidya","year":"1999","unstructured":"Vaidya B, Imrie H, Perros P et al (1999) Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphism confers susceptibility to thyroid associated orbitopathy. Lancet 354:743\u2013744. doi: 10.1016\/S0140-6736(99)01465-8","journal-title":"Lancet"},{"key":"919_CR27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","volume":"43","author":"MP Vanderpump","year":"1995","unstructured":"Vanderpump MP, Tunbridge WM, French JM et al (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 43:55\u201368. doi: 10.1111\/j.1365-2265.1995.tb01894.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"919_CR28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/1074-7613(94)90071-X","volume":"1","author":"TL Walunas","year":"1994","unstructured":"Walunas TL, Lenschow DJ, Bakker CY et al (1994) CTLA-4 can function as a negative regulator of T cell activation. Immunity 1:405\u2013413. doi: 10.1016\/1074-7613(94)90071-X","journal-title":"Immunity"},{"key":"919_CR29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1056\/NEJM200010263431707","volume":"343","author":"AP Weetman","year":"2000","unstructured":"Weetman AP (2000) Graves\u2019 disease. N Engl J Med 343:1236\u20131248. doi: 10.1056\/NEJM200010263431707","journal-title":"N Engl J Med"},{"key":"919_CR30","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jcem-44-1-203","volume":"44","author":"SC Werner","year":"1977","unstructured":"Werner SC (1977) Modification of the classification of the eye changes of Graves\u2019 disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44:203\u2013204","journal-title":"J Clin Endocrinol Metab"},{"key":"919_CR31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1631\/jzus.2006.B0887","volume":"7","author":"Q Zhang","year":"2006","unstructured":"Zhang Q, Yang YM, Lv XY (2006) Association of Graves\u2019 disease and Graves\u2019 ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyte associated antigen-4 gene. J Zhejiang Univ Sci B 7:887\u2013891. doi: 10.1631\/jzus.2006.B0887","journal-title":"J Zhejiang Univ Sci B"},{"key":"919_CR32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00439-005-0006-z","volume":"118","author":"A Zhernakova","year":"2005","unstructured":"Zhernakova A, Eerligh P, Barrera P et al (2005) CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet 118:58\u201366. doi: 10.1007\/s00439-005-0006-z","journal-title":"Hum Genet"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0919-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00403-008-0919-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-008-0919-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T13:37:40Z","timestamp":1559050660000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00403-008-0919-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,27]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["919"],"URL":"https:\/\/doi.org\/10.1007\/s00403-008-0919-1","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,27]]}}}